Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,050
+10 (0.08%)
Sep 12, 2025, 7:48 AM KST
Market Cap233.92B -14.7%
Revenue (ttm)276.09B +47.9%
Net Income15.60B
EPS886.73
Shares Out17.92M
PE Ratio14.72
Forward PEn/a
Dividend150.00 (1.15%)
Ex-Dividend DateDec 29, 2025
Volume22,452
Average Volume19,311
Open13,040
Previous Close13,040
Day's Range12,950 - 13,150
52-Week Range9,540 - 15,490
Beta0.64
RSI54.62
Earnings DateFeb 13, 2026

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 666
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements